保元汤加味联合华法林治疗非瓣膜性心房颤动临床研究
DOI:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R541.7+5

基金项目:


Clinical Study on Modified Baoyuan Tang Combined with Warfarin for Non- Valvular Atrial Fibrillation
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察保元汤加味联合华法林治疗非瓣膜性心房颤动的临床疗效。方法:选取非瓣膜性心房颤动患者96 例,按随机数字表法分为对照组和观察组各48 例。在降压、降糖、调脂等常规治疗的基础上,对照组给予华法林治疗;观察组在对照组的基础上加用保元汤加味内服。疗程均为3 个月,比较2 组心房颤动发作持续时间、发作频率,比较2 组治疗前后凝血功能[凝血酶原时间(PT)、活化部分凝血活酶时间(APTT)、凝血酶时间(TT)、国际标准化比值(INR)]、血浆N 末端B 型利钠肽原(NT-proBNP) 水平。结果:治疗后,2 组心房颤动的发作时间、频率均较治疗前下降(P<0.05),且观察组2 项指标改善较对照组更显著(P<0.05)。治疗后,2 组PT、APTT、TT、INR 均较治疗前明显升高(P<0.05),且观察组上述各项指标均高于对照组(P<0.05)。治疗后,2 组血浆NT-proBNP 水平较治疗前降低(P<0.05),且观察组NT-proBNP 水平低于对照组(P<0.05)。结论:保元汤加味联合华法林治疗非瓣膜性心房颤动疗效肯定,可有效改善患者凝血功能及心功能。

    Abstract:

    Abstract: Objective: To observe the clinical effect of modified Baoyuan tang combined with warfarin for non- valvular atrial fibrillation. Methods:A total of 96 cases of patients with non-valvular atrial fibrillation were selected and divided into the control group and the observation group according to the random number table method,with 48 cases in each group. Based on routine treatment including lowering blood pressure,lowering blood glucose and regulating lipid,the control group was additionally treated with warfarin;the observation group was additionally given the oral administration of modified Baoyuan tang based on the treatment of the control group. Both groups were treated for three months. The duration and frequency of atrial fibrillation in the two groups were compared. Before and after treatment,the coagulation function including prothrombin time(PT), activated partial thromboplastin time(APTT), thrombin time(TT) and international normalized ratio(INR), and contents of N-terminal B-type natriuretic peptide(NT-proBNP) in plasma in the two groups were compared. Results:After treatment,the onset time and frequency of atrial fibrillation in the two groups were shortened or decreased when compared with those before treatment(P<0.05), and the improvement of the two indexes in the observation group was more significant than that in the control group(P<0.05). After treatment, PT, APTT, TT and INR in the two groups were significantly increased when compared with those before treatment(P<0.05),and the above indexes in the observation group were higher than those in the control group(P<0.05). After treatment,the levels of plasma NT-proBNP in the two groups were decreased when compared with those before treatment(P<0.05),and the level in the observation group was lower than that in the control group(P<0.05). Conclusion: The therapy of modified Baoyuan tang combined with warfarin for non- valvular atrial fibrillation has a definite curative effect, and can effectively improve the coagulation function and heart function of patients.

    参考文献
    相似文献
    引证文献
引用本文

盛海涛,姚波,王爱玲.保元汤加味联合华法林治疗非瓣膜性心房颤动临床研究[J].新中医,2021,53(22):30-32

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2021-11-26
  • 出版日期: